Relationship of Wnt Pathway Activity and Organ Involvement in Scleroderma Types

dc.contributor.author Kocak, Ayse
dc.contributor.author Harmancı, Duygu
dc.contributor.author Akdoğan, Gül
dc.contributor.author Birlik, Merih
dc.date.accessioned 2023-06-16T14:31:13Z
dc.date.available 2023-06-16T14:31:13Z
dc.date.issued 2020
dc.description.abstract Objective Scleroderma (SSc) is a chronic inflammatory autoimmune disease characterized by fibrosis in the skin and internal organs. In SSc, the heart, lung, kidney, gastrointestinal (GIS) system, muscle, and peri-articular structures are damaged. There is no study of the relationship between SSc type, stage, pathogenesis, organ involvement, and Wnt signaling. In this study, we aimed to show the relationship of the Wnt gene family and antagonists in SSc subtypes and different organ involvement. Methods Eighty-five SSc patients and 77 controls were included in this study. The gene expressions and protein levels of the Wnt family and antagonists were analyzed from blood samples. The relationship between these parameters and disease stage, type, and organ involvement were evaluated. Results Wnt-1, Wnt-10b, Wnt-2, and Wnt-6 gene expressions are increased and Axin-2, DKK-1, and Kremen protein expressions are decreased in SSc. Wnt-3a and Wnt-10a gene expressions are increased in generalized SSc compared to limited SSc. Wnt-1, Wnt-2 gene expressions are increased significantly in pulmonary arterial hypertension (PAH)(+) SSc compared to PAH(-) SSc. There was a positive correlation between the modified Rodnan skin score and Wnt-2 in SSc. There was a significant positive correlation between GIS involvement score and Wnt-1, Wnt-2, Wnt-4, Wnt-8a, Wnt-9b in SSc. Conclusion Wnt-1 and Wnt-2 were found higher in scleroderma and organ involvement. They may play a role in the pathogenesis of the disease. en_US
dc.description.sponsorship TUBITAK [117S397] en_US
dc.description.sponsorship TUBITAK, Grant/Award Number: 117S397 en_US
dc.identifier.doi 10.1111/1756-185X.13973
dc.identifier.issn 1756-1841
dc.identifier.issn 1756-185X
dc.identifier.scopus 2-s2.0-85091689267
dc.identifier.uri https://doi.org/10.1111/1756-185X.13973
dc.identifier.uri https://hdl.handle.net/20.500.14365/2034
dc.language.iso en en_US
dc.publisher Wiley en_US
dc.relation.ispartof Internatıonal Journal of Rheumatıc Dıseases en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject organ involvement en_US
dc.subject scleroderma en_US
dc.subject Wnt antagonists en_US
dc.subject Wnt signaling pathway en_US
dc.subject Cutaneous Systemic-Sclerosis en_US
dc.subject Signaling Pathways en_US
dc.subject Skin Fibrosis en_US
dc.subject Beta-Catenin en_US
dc.subject Disease en_US
dc.subject Antagonists en_US
dc.subject Improvement en_US
dc.subject Inhibition en_US
dc.subject Expression en_US
dc.subject Therapy en_US
dc.title Relationship of Wnt Pathway Activity and Organ Involvement in Scleroderma Types en_US
dc.type Article en_US
dspace.entity.type Publication
gdc.author.id Kocak, Ayse/0000-0002-1510-2937
gdc.author.id Kocak, Ayse/0000-0002-1510-2937
gdc.author.id Birlik, Ahmet Merih/0000-0001-5118-9307
gdc.author.scopusid 57196089710
gdc.author.scopusid 55935858800
gdc.author.scopusid 55936538800
gdc.author.scopusid 6603398650
gdc.author.wosid Kocak, Ayse/W-3229-2017
gdc.author.wosid Kocak, Ayse/AAZ-7831-2020
gdc.author.wosid Birlik, Ahmet Merih/AIA-2552-2022
gdc.bip.impulseclass C5
gdc.bip.influenceclass C5
gdc.bip.popularityclass C5
gdc.coar.access metadata only access
gdc.coar.type text::journal::journal article
gdc.collaboration.industrial false
gdc.description.department İzmir Ekonomi Üniversitesi en_US
gdc.description.departmenttemp [Kocak, Ayse] Kutahya Hlth Sci Univ, Kutahya, Turkey; [Harmancı, Duygu; Birlik, Merih] Dokuz Eylul Univ, Izmir, Turkey; [Guner Akdogan, Gul] Izmir Univ Econ, Izmir, Turkey en_US
gdc.description.endpage 1567 en_US
gdc.description.issue 11 en_US
gdc.description.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
gdc.description.scopusquality Q3
gdc.description.startpage 1558 en_US
gdc.description.volume 23 en_US
gdc.description.wosquality Q3
gdc.identifier.openalex W3090106749
gdc.identifier.pmid 32996251
gdc.identifier.wos WOS:000573529600001
gdc.index.type WoS
gdc.index.type Scopus
gdc.index.type PubMed
gdc.oaire.diamondjournal false
gdc.oaire.downloads 0
gdc.oaire.impulse 1.0
gdc.oaire.influence 2.5343028E-9
gdc.oaire.isgreen true
gdc.oaire.keywords Adult
gdc.oaire.keywords Aged, 80 and over
gdc.oaire.keywords Male
gdc.oaire.keywords Middle Aged
gdc.oaire.keywords Prognosis
gdc.oaire.keywords Wnt Proteins
gdc.oaire.keywords Young Adult
gdc.oaire.keywords Scleroderma, Limited
gdc.oaire.keywords Case-Control Studies
gdc.oaire.keywords Scleroderma, Diffuse
gdc.oaire.keywords Disease Progression
gdc.oaire.keywords Humans
gdc.oaire.keywords Female
gdc.oaire.keywords Wnt Signaling Pathway
gdc.oaire.keywords Aged
gdc.oaire.popularity 3.6100958E-9
gdc.oaire.publicfunded false
gdc.oaire.sciencefields 0301 basic medicine
gdc.oaire.sciencefields 03 medical and health sciences
gdc.oaire.sciencefields 0302 clinical medicine
gdc.oaire.views 4
gdc.openalex.collaboration National
gdc.openalex.fwci 0.1439
gdc.openalex.normalizedpercentile 0.5
gdc.opencitations.count 3
gdc.plumx.crossrefcites 1
gdc.plumx.mendeley 14
gdc.plumx.pubmedcites 2
gdc.plumx.scopuscites 6
gdc.scopus.citedcount 6
gdc.virtual.author Akdoğan, Gül
gdc.wos.citedcount 6
relation.isAuthorOfPublication 4c485711-f05e-4293-a877-512e03de58f6
relation.isAuthorOfPublication.latestForDiscovery 4c485711-f05e-4293-a877-512e03de58f6
relation.isOrgUnitOfPublication 4cbb0a74-ee1a-438b-b714-b8ef253df94b
relation.isOrgUnitOfPublication fbc53f3e-d1d3-4168-afd8-e42cd20bddd9
relation.isOrgUnitOfPublication e9e77e3e-bc94-40a7-9b24-b807b2cd0319
relation.isOrgUnitOfPublication.latestForDiscovery 4cbb0a74-ee1a-438b-b714-b8ef253df94b

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
2034.pdf
Size:
1.52 MB
Format:
Adobe Portable Document Format